Latest 10-K annual reports

NanoViricides, Inc. reports progress in broad-spectrum antiviral drug NV-387's clinical development, including Phase Ia/Ib completion, but faces significant financial constraints and a going concern doubt.

Lesaka Technologies reports significant net losses and internal control weaknesses for fiscal 2025, despite revenue growth driven by strategic acquisitions and expansion in Southern Africa's fintech market.

Anebulo Pharmaceuticals is prioritizing the development of an intravenous selonabant formulation for pediatric cannabis poisoning, while reporting continued operating losses and proposing a reverse stock split to go private.

Escalon Medical Corp. reported a slight increase in net revenue for fiscal year 2025, but auditors continue to express substantial doubt about the company's ability to continue as a going concern.

Precision Optics Corporation, Inc. reported a significant increase in net loss and a sharp decline in gross margin for the fiscal year ended June 30, 2025, despite flat revenues and successful capital raises.

NeoVolta, Inc. announced a significant increase in annual revenue for fiscal year 2025, driven by sales channel expansion, but reported a more than doubling of its net loss and increased cash burn.

Vail Resorts reports increased fiscal 2025 EBITDA and strategic capital investments, alongside a Whistler Blackcomb credit facility extension and reduction, while facing declining pass units and economic uncertainties.

5E Advanced Materials progresses its Fort Cady boron and lithium project with a $435 million Phase 1 capital estimate, targeting 2028 commercial production, despite ongoing significant losses and substantial doubt about its ability to continue as a going concern.

SR Bancorp, Inc. reported a significant increase in net income for the fiscal year ended June 30, 2025, driven by loan growth and strategic balance sheet restructuring, despite a material weakness in internal controls.

Lunai Bioworks Inc. reported a significant increase in net loss for fiscal year 2025, alongside a subsidiary's bankruptcy and ongoing legal challenges, raising substantial doubt about its ability to continue as a going concern.

Cavitation Technologies, Inc. reported a net loss of $113,000 for fiscal year 2025, a significant decline from the prior year's profit, as it shifts focus to new ventures in water treatment and alcoholic beverages.

Leafbuyer Technologies, Inc. reported a net profit of $260,672 for the fiscal year ended June 30, 2025, marking a significant turnaround from the previous year's loss, driven by revenue growth and cost efficiencies.

NetSol Technologies reports a 7.6% revenue growth and a 327% increase in net income for FY 2025, driven by subscription and services growth.

C2 Blockchain, Inc. reported a significant net loss of $235,265 for fiscal year 2025, highlighting its development-stage status and reliance on external financing for future cryptocurrency mining and digital asset initiatives.

Incannex Healthcare Inc. reported a significant increase in net loss for fiscal year 2025, driven by financing activities, while advancing its lead drug candidates IHL-42X and PSX-001 through clinical trials.

Marine Petroleum Trust, a royalty trust, reported a slight increase in distributable income for fiscal year 2025, driven by higher natural gas and NGL royalties despite a decline in oil production and prices.

Moving iMage Technologies, Inc. filed an amended annual report for fiscal year 2025, correcting an auditor report date and detailing a reduced net loss despite a revenue decline.

Franklin Wireless Corp. announced a significant increase in net sales and a substantial reduction in its net loss for fiscal year 2025, driven by strong North American demand.

Amplify Commodity Trust's 2025 annual report reveals significant net asset value declines for its Dry Bulk and Tanker Shipping ETFs amid challenging market conditions and geopolitical disruptions.

Biomerica, Inc. filed an amendment to its 2025 Annual Report, providing updated disclosures on corporate governance, executive compensation, and capital stock structure.

Copart, Inc. announced robust financial results for fiscal year 2025, with significant increases in service revenues, operating income, and net income, driven by U.S. market strength and international expansion.

Marathon Bancorp, Inc. successfully converted to a stock holding company, generating $16.9 million in gross proceeds, and reported a net income of $42,000 for fiscal year 2025, reversing a prior year loss.

Moving iMage Technologies reported a decrease in net sales but an improved net loss for fiscal year 2025, alongside key management changes and strategic product initiatives.

Lite Strategy, Inc., formerly MEI Pharma, has completed a $100 million PIPE and fully deployed proceeds into a Litecoin Treasury Strategy, marking a significant shift from its pharmaceutical development focus.

Home Federal Bancorp, Inc. of Louisiana reported increased net income of $3.9 million for fiscal year 2025, despite a decrease in total assets and deposits, driven by higher non-interest income and reduced expenses.

Ferguson Enterprises Inc. announced a 3.8% increase in net sales and a 9.3% rise in diluted earnings per share for fiscal year 2025, driven by higher sales volume and strategic acquisitions.

Datasea Inc. announced a significant 198.70% revenue increase to $71.62 million for fiscal year 2025, driven by its AI multimodal digital and acoustic high-tech businesses, while substantially reducing its net loss.

Donaldson Company, Inc. reported a decrease in net earnings and diluted EPS for fiscal year 2025, primarily due to a significant impairment charge in its Life Sciences segment.

Cracker Barrel Old Country Store, Inc. reported a slight revenue increase and improved operating income in fiscal 2025, driven by strategic pricing and labor efficiencies, despite ongoing macroeconomic challenges and a negative response to its new logo.

Ultimate Holdings Group, a blank check company, reported a wider net loss of $261,125 for fiscal year 2025 and faces substantial doubt about its ability to continue as a going concern.